Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Peeters

Showing results (61-70 of 101) with videos related to

Pageof 11
Sort By:
The Journal of Cardiovascular Surgery|May 27, 2017
BeGraft Peripheral PMCF Study: 12-month resultsKoen Deloose, Marc Bosiers, Joren Callaert, et al.
Annals of Transplantation|August 30, 2017
Effect of Magnesium Supplements on Insulin Secretion After Kidney Transplantation: A Randomized Controlled TrialSteven Van Laecke, Rogier Caluwe, Inge Huybrechts, et al.
Journal of Clinical Immunology|September 10, 2021
Determinants and Reference Ranges of Serum Immunoglobulins in Middle-Aged and Elderly Individuals: a Population-Based StudySamer Raza Khan, Layal Chaker, Mohammad Arfan Ikram, et al.
The Journal of Cardiovascular Surgery|July 12, 2019
Improvements in patient outcomes with next generation endovascular aortic repair devices in the ENGAGE Global Registry and the EVAR-1 clinical trialDittmar Böckler, Adam H Power, Lee H Bouwman, et al.
JACC. Cardiovascular Interventions|October 24, 2015
Paclitaxel-Coated Balloon in Infrapopliteal Arteries: 12-Month Results From the BIOLUX P-II Randomized Trial (BIOTRONIK'S-First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularization of infrapopliteal arteries)Thomas Zeller, Ulrich Beschorner, Ernst Pilger, et al.
Transplant Immunology|June 17, 2018
The clinical significance of epitope mismatch load in kidney transplantation: A multicentre studyLiesbeth Daniëls, Maarten Naesens, Jean-Louis Bosmans, et al.
Journal of the American College of Cardiology|February 16, 2019
Drug-Eluting Stent Versus Drug-Coated Balloon Revascularization in Patients With Femoropopliteal Arterial DiseaseYvonne Bausback, Tim Wittig, Andrej Schmidt, et al.
Journal of Vascular Surgery|December 16, 2011
Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive diseaseMarc Bosiers, Dierk Scheinert, Patrick Peeters, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|September 3, 2020
Combining the Passeo-18 Lux Drug-Coated Balloon and the Pulsar-18 Bare Metal Stent: 12- and 24-Month Outcomes of the BIOLUX 4EVER Investigator-Initiated TrialKoen Deloose, Marc Bosiers, Patrick Peeters, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|December 12, 2013
4-French-compatible endovascular material is safe and effective in the treatment of femoropopliteal occlusive disease: results of the 4-EVER trialMarc Bosiers, Koen Deloose, Joren Callaert, et al.
Pageof 11

Showing results (61-70 of 101) with videos related to

Sort By:
Pageof 11
The Journal of Cardiovascular Surgery|May 27, 2017
BeGraft Peripheral PMCF Study: 12-month resultsKoen Deloose, Marc Bosiers, Joren Callaert, et al.
Annals of Transplantation|August 30, 2017
Effect of Magnesium Supplements on Insulin Secretion After Kidney Transplantation: A Randomized Controlled TrialSteven Van Laecke, Rogier Caluwe, Inge Huybrechts, et al.
Journal of Clinical Immunology|September 10, 2021
Determinants and Reference Ranges of Serum Immunoglobulins in Middle-Aged and Elderly Individuals: a Population-Based StudySamer Raza Khan, Layal Chaker, Mohammad Arfan Ikram, et al.
The Journal of Cardiovascular Surgery|July 12, 2019
Improvements in patient outcomes with next generation endovascular aortic repair devices in the ENGAGE Global Registry and the EVAR-1 clinical trialDittmar Böckler, Adam H Power, Lee H Bouwman, et al.
JACC. Cardiovascular Interventions|October 24, 2015
Paclitaxel-Coated Balloon in Infrapopliteal Arteries: 12-Month Results From the BIOLUX P-II Randomized Trial (BIOTRONIK'S-First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularization of infrapopliteal arteries)Thomas Zeller, Ulrich Beschorner, Ernst Pilger, et al.
Transplant Immunology|June 17, 2018
The clinical significance of epitope mismatch load in kidney transplantation: A multicentre studyLiesbeth Daniëls, Maarten Naesens, Jean-Louis Bosmans, et al.
Journal of the American College of Cardiology|February 16, 2019
Drug-Eluting Stent Versus Drug-Coated Balloon Revascularization in Patients With Femoropopliteal Arterial DiseaseYvonne Bausback, Tim Wittig, Andrej Schmidt, et al.
Journal of Vascular Surgery|December 16, 2011
Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive diseaseMarc Bosiers, Dierk Scheinert, Patrick Peeters, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|September 3, 2020
Combining the Passeo-18 Lux Drug-Coated Balloon and the Pulsar-18 Bare Metal Stent: 12- and 24-Month Outcomes of the BIOLUX 4EVER Investigator-Initiated TrialKoen Deloose, Marc Bosiers, Patrick Peeters, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|December 12, 2013
4-French-compatible endovascular material is safe and effective in the treatment of femoropopliteal occlusive disease: results of the 4-EVER trialMarc Bosiers, Koen Deloose, Joren Callaert, et al.
Pageof 11